Easily accessible and clinically focused, Abeloff's Clinical Oncology, 6th Edition, covers recent advances in our
understanding of the pathophysiology of cancer, cellular and molecular causes of cancer initiation and progression,
new and emerging therapies, current trials, and much more. Masterfully authored by an international team of leading
cancer experts, it offers clear, practical coverage of everything from basic science to multidisciplinary collaboration
on diagnosis, staging, treatment and follow up.
• Includes new chapters on Cancer Metabolism and Clinical Trial Designs in Oncology and a standalone
chapter on lifestyles and cancer prevention.
• Features extensive updates including the latest clinical practice guidelines, decision-making algorithms, and
clinical trial implications, as well as new content on precision medicine, genetics, and PET/CT imaging.
• Includes revised diagnostic and treatment protocols for medical management, surgical considerations, and
radiation oncology therapies, stressing a multispecialty, integrated approach to care.
• Helps you find information quickly with updated indexing related to management recommendations, focused
fact summaries, updated key points at the beginning of each chapter ideal for quick reference and board
review, and algorithms for patient evaluation, diagnosis, and treatment options.
• Offers more patient care coverage in disease chapters, plus new information on cancer as a chronic illness
and cancer survivorship.
• Discusses today’s key topics such as immuno-oncology, functional imaging, precision medicine, the
application of genetics in pathologic diagnosis and sub-categorization of tumors as well as the association of
chronic infectious diseases such as HIV and cancer.
• Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the
text, figures, and references from the book on a variety of devices.
PART I Science and Clinical Oncology
Section A Biology and Cancer
1. Molecular Tools in Cancer Research, 2
2. Intracellular Signaling, 24
3. The Cellular Microenvironment and Metastases. 47
4. Control of the Cell Cycle, 56
5. Pathophysiology of Cancer Cell Death, 74
6. Cancer Immunology, 84
7. Stem Cells, Cell Differentiation, and Cancer, 97
8. Tumor Microenvironment: Vascular and Extravascular Compartment, 108
9. Cancer Metabolism, 127
Section B Genesis of Cancer
10. Environmental Factors, 139
11. DNA Damage Response Pathways and Cancer, 154
12. Viruses and Human Cancer, 165
13. Genetic Factors: Hereditary Cancer Predisposition Syndromes, 180
14. Genetic and Epigenetic Changes in Cancer, 209
Section C Diagnosis of Cancer
15. Pathology, Biomarkers, and Molecular Diagnostics, 225
16. Imaging, 254
Section D Clinical Trials
17. Biostatistics and Bioinformatics in Clinical Trials, 284
18. Clinical Trial Designs in Oncology, 296
19. Structures Supporting Cancer Clinical Trials, 308
20. Oncology and Health Care Policy, 317
Section E Prevention and Early Detection
21. Discovery and Characterization of Cancer Genetic Susceptibility Alleles, 323
22. Lifestyle and Cancer Prevention, 337
23. Screening and Early Detection, 375
24. Nicotine Dependence: Current Treatments and Future Directions, 399
Section F Treatment
25. Cancer Pharmacology, 411
26. Therapeutic Targeting of Cancer Cells: Era of Molecularly Targeted Agents, 420
27. Basics of Radiation Therapy, 431
28. Hematopoietic Stem Cell Transplantation, 461
29. Gene Therapy in Oncology, 470
30. Therapeutic Antibodies and Immunologic Conjugates, 486
31. Complementary and Alternative Medicine, 500
PART II Problems Common to Cancer and Therapy
Section A Hematologic Problems and Infections
32. Disorders of Blood Cell Production in Clinical Oncology, 514
33. Diagnosis, Treatment, and Prevention of Cancer-Related Venous Thrombosis, 523
34. Infection in the Patient with Cancer, 544
Section B Symptom Management
35. Hypercalcemia, 565
36. Tumor Lysis Syndrome, 572
37. Cancer-Related Pain, 581
38. Cancer Cachexia, 593
39. Nausea and Vomiting, 598
Section C Treatment Complications
40. Oral Complications, 607
41. Dermatologic Toxicities of Anticancer Therapy, 621
42. Cardiovascular Effects of Cancer Therapy, 649
43. Reproductive Complications, 665
44. Paraneoplastic Neurologic Syndromes, 676
45. Neurologic complications, 688
46. Endocrine Complications, 707
47. Pulmonary Complications of Anticancer Treatment, 715
Section D Posttreatment Considerations
48. Rehabilitation of Individuals with Cancer, 725
49. Survivorship, 732
50. Second Malignant Neoplasms, 741
51. Caring for Patients at the End of Life, 751
Section E Local Effects of Cancer and Its Metastasis
52. Acute Abdomen, Bowel Obstruction, and Fistula, 764
53. Superior Vena Cava Syndrome, 775
54. Spinal Cord Compression. 786
55. Brain Metastases and Neoplastic Meningitis, 794
56. Bone Metastases, 809
57. Lung Metastases, 831
58. Liver Metastases, 846
59. Malignancy-Related Effusions, 863
Section F Special Populations
60. Cancer in the Elderly: Biology, Prevention, and Treatment, 874
61. Special Issues in Pregnancy, 882
62. Human Immunodeficiency Virus (HIV) Infection and Cancer, 894
PART III Specific Malignancies
Section A Central Nervous System
63. Cancer of the Central Nervous System, 906
Section B Head, Neck, and Eye
64. Ocular Tumors, 968
65. Cancer of the Head and Neck, 999
Section CSkin
66. Melanoma, 1034
67. Nonmelanoma Skin Cancers: Basal Cell and Squamous Cell Carcinomas, 1052
Section D Endocrine
68. Cancer of the Endocrine System, 1074
Section E Thoracic
69. Cancer of the Lung: Non-Small Cell Lung Cancer and Small Cell Lung Cancer, 1108
70. Diseases of the Pleura and Mediastinum, 1159
71. Cancer of the Esophagus, 1174
Section F Gastrointestinal
72. Cancer of the Stomach, 1197
73. Cancer of the Small Bowel, 1211
74. Colon Cancer, 1219
75. Cancer of the Rectum, 1281
76. Cancer of the Anal Canal, 1300
77. Liver and Bile Duct Cancer, 1314
78. Carcinoma of the Pancreas, 1342
Section G Genitourinary
79. Cancer of the Kidney, 1361
80. Carcinoma of the Bladder, 1382
81. Prostate Cancer, 1401
82. Cancer of the Penis, 1433
83. Testicular Cancer, 1442
Section H Gynecological
84. Cancers of the Cervix, Vulva, and Vagina, 1468
85. Uterine Cancer, 1508
86. Carcinoma of the Ovaries and Fallopian Tubes, 1525
87. Gestational Trophoblastic Disease, 1544
88. Cancer of the Breast, 1560
Section I Sarcomas
89. Sarcomas of Bone, 1604
90. Sarcomas of Soft Tissue, 1655
Section J Cancer of Undefined Site of Origin
91. Carcinoma of Unknown Primary 1694
Section K Pediatrics
92. Pediatric Solid Tumors, 1703
93. Childhood Leukemia, 1748
94. Childhood Lymphoma, 1765
Section L Hematological
95. Acute Leukemias in Adults, 1783
96. Myelodysplastic Syndromes, 1798
97. Myeloproliferative Disorders, 1821
98. Chronic Myeloid Leukemia, 1836
99. Chronic Lymphoid Leukemias, 1850
100. Hairy Cell Leukemia, 1872
101. Multiple Myeloma and Related Disorders, 1884
102. Hodgkin’s Lymphoma, 1911
103. Non-Hodgkin Lymphoma, 1926
104. Cutaneous T-Cell Lymphoma and Cutaneous B-Cell Lymphoma, 1948
105. Adult T-Cell Leukemia-Lymphoma, 1965